Public Private Partnerships: A working model for open innovation in Drug Discovery

Niamh Madigan

Looking to comprehensive strategies for structuring and funding innovation driven in non-clinical co-operations through the experiences of the Structural Genomics Consortium (SGC) at University of Oxford. Dr Wen Hwa Lee, the Strategic Alliances Manager talks to Pharma IQ on benefitting from pre-competitive research and shares insight in a compound discovery case study and the journey involved to  bring this into the public domain. Have Your Say Rate...
To continue reading this story get free access